Doctor profile · Federal record
Dr. Karl Saardi, M.D.
Dermatology Physician (CMS: Dermatology) · Internal Medicine Physician · Washington, DC
- NPI 1114312410
- Accepts Medicare
- 11 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2150 Pennsylvania Ave Nw Ste 2B-430
Washington, DC 200373201
(202) 741-3000
fax (202) 869-8361
Credentials & registration
- NPI registered
- April 2015 — 11 yrs on file
- Profile last updated
- June 30, 2020
- Year of graduation
- 2015 — 11 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- District of Columbia #MD048379
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1114312410. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
947
Distinct HCPCS
10
Medicare allowed
$88,752
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 203 | 165 | $103 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 141 | 105 | $144 | |
96900 |
Application of ultraviolet light to skin | 104 | 15 | $30 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 70 | 22 | $8 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 66 | 66 | $126 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 49 | 49 | $190 | |
17000 |
Destruction of precancer skin growth, 1 growth | 45 | 36 | $73 | |
11104 |
Punch biopsy, first skin growth | 43 | 41 | $147 | |
11102 |
Biopsy of related skin growth, first growth | 40 | 39 | $113 | |
17110 |
Destruction of skin growth, 1-14 growths | 38 | 31 | $131 |
In context: peer comparison
Among 24 peers in Washington Dermatology Physician, average services per provider: 200. This provider delivers 4.7× the peer median.Open Payments
Industry payments received
All-time total
$61,076
Transactions
103
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | 33 | $42,765.17 | |
| Ucb, INC. | 10 | $12,550.17 | |
| Galderma Laboratories, L.P. | 2 | $4,012.27 | |
| Abbvie INC. | 18 | $345.97 | |
| E.R. Squibb & Sons, L.L.C. | 4 | $295.49 | |
| Novartis Pharmaceuticals Corporation | 8 | $217.04 | |
| Janssen Biotech, INC. | 4 | $153.84 | |
| Lilly USA, LLC | 5 | $130.75 | |
| Amgen INC. | 4 | $113.97 | |
| Incyte Corporation | 4 | $95.77 | |
| Leo Pharma INC. | 3 | $71.53 | |
| Pfizer INC. | 3 | $48.98 | |
| Regeneron Healthcare Solutions, INC. | 2 | $47.68 | |
| Arcutis Biotherapeutics, INC. | 2 | $43.37 | |
| Merck Sharp & Dohme LLC | 1 | $34.62 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
396
Patients
115
Total drug cost
$577,081
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 67 | 38 | $1,174 |
| Clobetasol Propionate | Generic | 65 | 37 | $4,202 |
| Ketoconazole | Generic | 40 | 14 | $755 |
| Dupixent Pen (Dupilumab) | Brand | 33 | 0 | $126,851 |
| Clindamycin Phosphate | Generic | 31 | 0 | $2,788 |
| Humira(Cf) Pen (Adalimumab) | Brand | 24 | 0 | $374,174 |
| Mometasone Furoate | Generic | 18 | 0 | $276 |
| Tacrolimus | Generic | 18 | 0 | $1,818 |
| Ammonium Lactate | Generic | 17 | 0 | $414 |
| Fluorouracil | Generic | 17 | 15 | $1,666 |
Frequently asked questions
What is Dr. Karl Saardi's medical specialty?
Dr. Karl Saardi practices Dermatology Physician in Washington, DC.
Where does Dr. Karl Saardi practice?
Dr. Karl Saardi practices at 2150 Pennsylvania Ave Nw Ste 2B-430, Washington, DC 200373201. Office phone: 2027413000.
What is Dr. Karl Saardi's NPI?
Dr. Karl Saardi's National Provider Identifier (NPI) is 1114312410, issued by NPPES.
Does Dr. Karl Saardi accept Medicare assignment?
Yes. Dr. Karl Saardi accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Karl Saardi commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99213); Established patient office or other outpatient visit (HCPCS 99214); Application of ultraviolet light to skin (HCPCS 96900). Source: CMS Medicare Physician & Other Practitioners file.